List of Excipients in API pheniramine maleate and naphazoline hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing pheniramine maleate and naphazoline hydrochloride
Detailed excipient profiles for pheniramine maleate and naphazoline hydrochloride
Excipient focus: BENZALKONIUM CHLORIDE
pheniramine maleate and naphazoline hydrochloride drug variants containing BENZALKONIUM CHLORIDE
pheniramine maleate and naphazoline hydrochloride drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
pheniramine maleate and naphazoline hydrochloride drug variants containing BORIC ACID
pheniramine maleate and naphazoline hydrochloride drug variants not containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
pheniramine maleate and naphazoline hydrochloride drug variants containing EDETATE DISODIUM
pheniramine maleate and naphazoline hydrochloride drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Wal-Mart Stores Inc | pheniramine maleate and naphazoline hydrochloride | 49035-430 |
| CVS Pharmacy | pheniramine maleate and naphazoline hydrochloride | 59779-042 |
| CVS Pharmacy | pheniramine maleate and naphazoline hydrochloride | 59779-552 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE SODIUM
pheniramine maleate and naphazoline hydrochloride drug variants containing EDETATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Wal-Mart Stores Inc | pheniramine maleate and naphazoline hydrochloride | 49035-430 |
| CVS Pharmacy | pheniramine maleate and naphazoline hydrochloride | 59779-042 |
| CVS Pharmacy | pheniramine maleate and naphazoline hydrochloride | 59779-552 |
| >Company | >Ingredient | >NDC |
pheniramine maleate and naphazoline hydrochloride drug variants not containing EDETATE SODIUM
Excipient focus: HYDROCHLORIC ACID
pheniramine maleate and naphazoline hydrochloride drug variants containing HYDROCHLORIC ACID
pheniramine maleate and naphazoline hydrochloride drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
pheniramine maleate and naphazoline hydrochloride drug variants containing HYPROMELLOSE
pheniramine maleate and naphazoline hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | pheniramine maleate and naphazoline hydrochloride | 59779-042 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
pheniramine maleate and naphazoline hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | pheniramine maleate and naphazoline hydrochloride | 59779-042 |
| >Company | >Ingredient | >NDC |
pheniramine maleate and naphazoline hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: SODIUM BORATE
pheniramine maleate and naphazoline hydrochloride drug variants containing SODIUM BORATE
pheniramine maleate and naphazoline hydrochloride drug variants not containing SODIUM BORATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
pheniramine maleate and naphazoline hydrochloride drug variants containing SODIUM CHLORIDE
pheniramine maleate and naphazoline hydrochloride drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
pheniramine maleate and naphazoline hydrochloride drug variants containing WATER
pheniramine maleate and naphazoline hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
